Filter:

Search Results

Sorry, Celgene, patent board says. Bass can challenge your IP, and profit, too

with more documentation, and he filed two new challenges against the drug's other patents, too. ...

Intersect ENT aims for physician office with trio of study results for steroid-releasing sinus implants

data on dissolving implants for chronic sinusitis are encouraging Intersect ENT files for $80M IPO ...

J&J's DePuy pushes back at medical funding for hip implants

have cost no more than $360,000, DePuy said in a federal court filing seen by the news outlet. ...

BI debuts two PRRS vaccines; Merck launches graduate fellowships; Jaguar starts trials for Neonorm Foal;

in horses, the majority of which had not been vaccinated against the disease. Article > Zoetis ($ZTS) ...

Roche scores an MS first with a potential blockbuster on its hands

is planning to file ocrelizumab for approval early next year, widening its intended label to include both ...

Ceva launches novel vaccine to protect pigs from common respiratory disease

farmers track bacterial pathogens and target vaccinations according to the needs of individual herds. ...

Sanofi rumored to be weighing Merial spinoff

which includes drugs, vaccines and digital tools.- read more at FiercePharma- here's the Bloomberg ...

USDA unveils plan to battle avian flu if it re-emerges this fall

of infected flocks, increased resources in the event of an outbreak and the development of vaccines. The agency recently gave Iowa-based HarrisVaccines the first conditional license for its avian influenza vaccine, RNA. U.S. Agriculture Secretary Tom Vilsack "We're obviously hoping for the best, ...

Fierce's coverage of the Martin Shkreli saga

brighter: Lawmakers filing bills and holding hearings, presidential candidates devising anti-price-hike ...

Novo scores a game-changing diabetes approval, reversing an embarrassing rejection

as safety concerns forced it to delay an FDA filing for its candidate, but the company has vowed to find ...